Please provide your email address to receive an email when new articles are posted on . Using extracorporeal life support early did not reduce death risk at 30 days in patients with MI and cardiogenic ...
MISSOULA, Mont. — Providence St. Patrick Hospital's new extracorporeal membrane oxygenation (ECMO) machine improves care for patients in critical need. The machine takes blood from the patient, ...
Early use of ECMO devices to support adults with cardiogenic shock did not improve clinical outcomes
The immediate use of veno-arterial mechanical circulatory extracorporeal membrane oxygenation (ECMO) devices to support adults with rapidly deteriorating or severe cardiogenic shock was feasible but ...
Extracorporeal life support (ECLS) is increasingly used in the treatment of infarct-related cardiogenic shock despite a lack of evidence regarding its effect on mortality. In this multicenter trial, ...
Extracorporeal cardiopulmonary resuscitation (CPR) restores perfusion and oxygenation in a patient who does not have spontaneous circulation. The evidence with regard to the effect of extracorporeal ...
Venoarterial extracorporeal membrane oxygenation (VA ECMO) for extracorporeal cardiopulmonary resuscitation (ECPR) can be used as an option to manage in-hospital and out-of-hospital refractory cardiac ...
Enrollment completed ahead of schedule in the global IDE for Abbott (ABT)'s Volt™ PFA System Global FOCALFLEX trial now underway for Abbott's TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ Advisor™ ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results